Visilizumab for Treatment of Perianal Fistulas in Crohn's Disease

NCT00267709 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

18

Enrollment

INDUSTRY

Sponsor class

Conditions

Crohn's Disease

Interventions

DRUG: Visilizumab

Sponsor

Facet Biotech

Collaborators

[object Object]